S U M M A R Y
TUBERCULOSIS (TB) remains a major public health problem, particularly in high human immunodeficiency virus (HIV) prevalence settings. 1 According to the World Health Organization's Global TB Report 2012, TB incidence rates in South Africa (993 cases per 100 000 population) are among the highest in sub-Saharan Africa, and 73% of new TB cases are coinfected with HIV. 2 Early diagnosis of TB is important to prevent transmission and reduce morbidity and mortality. 3, 4 Delays in the diagnosis and treatment of pulmonary TB result in longer duration of infectiousness and possible nosocomial transmission of TB within health care facilities. 5 Early detection of TB and rapid initiation of treatment is imperative to manage its spread.
Factors affecting delay in diagnosis and treatment of TB are widely reported in the literature, [3] [4] [5] [6] [7] [8] [9] [10] [11] and categorised into either patient or health care system delays, the sum of which is the total delay. Commonly reported predictors include sex, age, use of antibiotics that have activity against TB, employment status, alcohol use, smoking, residence in a rural area, literacy level, distance from a health facility and migration status in a foreign country. The delay may be due to the patient not contacting a medical facility in a timely fashion or as a result of a low suspicion index by health care workers in both low and high TB prevalence areas. 3, 9, 12 Although predictors of delays in TB diagnosis and treatment are widely reported, they are poorly understood in HIV co-infected immunesuppressed patients.
We examined factors associated with delays in TB diagnosis and treatment in HIV co-infected in-patients with active pulmonary TB admitted to three hospitals in South Africa: the Chris Hani Baragwanath Academic Hospital and Selby Park Hospital, both in Johannesburg, Gauteng Province, and Tshepong Hospital in North West Province.
STUDY POPULATION AND METHODS

Setting and study population
The Chris Hani Baragwanath Hospital in Soweto, Johannesburg, has approximately 3200 beds and admits approximately 100 adults per day to the medical wards. About 7000 patients are diagnosed with TB annually. Tshepong Hospital, in the Northwest Province, has approximately 800 beds; TB patients are treated in the 200-bed Medicine Department; 2100 patients are admitted per quarter, of whom 60% are HIVinfected and about half test positive for TB. Selby Park Hospital, in Johannesburg, has approximately 500 beds for patients referred from public hospitals, including the Chris Hani Baragwanath Academic Hospital.
We prepared a post-hoc analysis of data collected in a three-centre prospective cohort of in-patients differentially diagnosed with active TB (both pulmonary and extra-pulmonary) and enrolled during the fi rst 24 h of admission, as defi ned in the parent study. 13, 14 The parent study was an evaluation of mortality in TB patients. To be eligible for the study, patients had to be at least 18 years of age and TB had to be included in the differential diagnosis during the fi rst 24 h of admission. The study enrolled all adults, irrespective of HIV serostatus; however, this analysis is restricted to those who were confi rmed to have HIV infection. We measured delays in diagnosis and initiation of TB treatment and prior health-seeking behaviour by ascertaining the longest duration of any symptom of TB and time to fi rst presentation to a health care facility for this episode of illness. Sociodemographic data, physical examination and laboratory tests were recorded at initial recruitment.
Ethical approval was given by the institutional review boards of the University of the Witwatersrand, Johannesburg, and Johns Hopkins, Baltimore.
Definitions
Although there is no clear defi nition of prolonged or acceptable delay from onset of symptoms to receipt of anti-tuberculosis treatment, authors have defi ned prolonged delay as 1-2 months. 6, 7, 11 Patient delay is defi ned as the number of days between onset of TB symptoms and the fi rst contact with any health care provider, while system delay is defi ned as the number of days between admission and initiation of antituberculosis treatment. 'System' in this study refers to the hospital system. Total delay is the sum of patient and system delay. We defi ned prolonged patient delay as having symptoms for at least 28 days prior to seeking any health care. Similarly, prolonged health care system delay was defi ned as starting anti-tuberculosis treatment at least 7 days after fi rst reporting to any medical facility. Crowding index was defi ned as the number of people in a household divided by the rooms in the house.
Statistical analysis
Descriptive statistics of median and interquartile ranges (IQRs) were determined for continuous sociodemographic and clinical variables stratifi ed by sex. Overall frequencies of delay were determined for a number of socio-demographic and clinical variables. The median distribution and IQR for patient, health care system and total delay was determined. Univariate logistic regression models were fi t to determine odds ratios (ORs), 95% confi dence intervals (CIs) and associated P values. Variables with P < 0.05 were considered for entry into the multivariate model to determine predictors of patient, health care system and total delay in general and by sex. Model fi t was checked using Hosmer-Lemeshow goodness-of-fi t statistic. 15 Statistical analysis assumed a two-sided 5% significance level and was performed using SAS 9.2 (Statistical Analysis Software Institute, Cary, NC, USA).
RESULTS
A total of 891 HIV-infected participants with a clinical diagnosis of TB were recruited a median of 18.3 h (IQR 14.8-21.6) after admission to hospital. The most common symptoms that prompted patients to [IQR] or n (%) Males (n = 284) median [IQR] or n (%) Females (n = 607) median [IQR] or n (%) present to the hospital were cough (n = 437, 49%), chest pain (n = 84, 9%), fever (n = 22, 3%), shortness of breath (n = 98, 11%), vomiting (n = 30, 3%) and others (n = 220, 25%). Most (n = 607, 68%) were women; 366 (41%) were admitted to Chris Hani Baragwanath Hospital, 310 (35%) to Tshepong Hospital and 215 (24%) to Selby Park. The median age of women and men was respectively 34 (IQR 29-41) and 39 years (IQR 33-47; P < 0.0001; Table 1 ). The median CD4 count and log 10 viral load at enrolment was respectively 67 cells/mm 3 (males 73.5 cells/ mm 3 vs. females 66 cells/mm 3 , P = 0.75) and 5.2 (males 5.2 vs. females 5.1, P = 0.78). Alcohol use in men was signifi cantly higher than in women (50% vs. 18%, P < 0.0001). The time from fi rst recorded symptom to start of anti-tuberculosis treatment was not signifi cantly different by sex: the median time to starting anti-tuberculosis treatment from fi rst symptom was 29 days (IQR 21-57) for men and 28 days (IQR 17-56) for women (P = 0.3). Median patient, system and total delays were respectively 28, 1 and 28 days. Of those who experienced prolonged delays in patient (n = 270, 30%), health care system (n = 161, 18%) and total delays (n = 265, 30%), 67% were females. Longer delays were experienced by patients with WHO Stages 3 and 4 disease, those admitted to Tshepong Hospital, those aged >60 years, those who sought treatment elsewhere before enrolment, those who were unemployed, on cotrimoxazole and had a CD4 count of <350 cells/mm 3 . Sex, alcohol consumption and smoking status were not associated with total delay (Table 2) . In the multivariate model (Table 3) , unemployment (OR 1.6, 95%CI 1.004-2.4), being admitted to Tshepong Hospital (OR 2.6, 95%CI 1.6-4.3), consuming alcohol (OR 1.6, 95%CI 1.1-2.3) , seeking treatment elsewhere before admission (OR 1.7, 95%CI 1.1-2.5), taking cotrimoxazole (OR 2.1, 95%CI 1.3-3.3) and WHO Stage 4 disease (OR 1.6, 95%CI 1.1-2.4) predicted prolonged total delay. Separate regression models were run by sex due to the large differences observed between men and women ( Table 4) . Males who sought treatment in Tshepong Hospital (OR 4.6, 95%CI 2.1-9.8) and consumed alcohol (OR 2.4, 95%CI 1.3-4.4) had higher odds of experiencing total delay, while crowding index was protective (OR 0.8, 95%CI 0.6-0.996). Females were likely to experience total delay if they were unemployed (OR 1.8, 95%CI 1.003-3.1), were admitted to Tshepong Hospital (OR 2.5, 95%CI 1.4-4.5), had sought prior treatment elsewhere before admission (OR 1.7, 95%CI 1.1-2.7) and were taking cotrimoxazole (OR 2.4, 95%CI 1.4-4.0).
DISCUSSION
Despite the wide body of literature available on predictors of delays in TB diagnosis and treatment, there is a paucity of information on TB in-patients co-infected with HIV. In our study of delays in initiation of anti-tuberculosis treatment in hospitalised HIV co-infected patients, several factors were noted to be associated with prolonged delays of over 28 days from start of symptoms.
Our fi ndings provide insight from a region with high TB and HIV incidence rates, covering both a semi-rural and urban setting. Participants in this study had a low CD4 count and high HIV viral loads at the time of admission. TB patients co-infected with HIV 
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1203 are likely to deteriorate more quickly than those who are HIV-negative. 16, 17 The level of socio-economic status has been linked to health care seeking behaviour of individuals. As in Brazil, 6 Tanzania 18 and Hong Kong, 19 we observed that the unemployed were more likely to experience delays in diagnosis and treatment of TB. The relationship between poverty and TB continues, as reported in a pilot study on a new tool for estimating patients' costs in Kenya. 20 The median time from admission to start of antituberculosis treatment was 1 day. Delays in initiation of anti-tuberculosis treatment can result in nosocomial transmission of TB and may extend the total duration of hospitalisation, which has an impact on the cost of caring for people with HIV. 21 Analysis by sex showed that unemployed women were more likely to experience both patient and total delays. We posit that economic empowerment of females in this cohort is low, limiting prompt access to health care, as shown by the low proportion employed. Those seeking treatment in Tshepong Hospital, which serves a semi-rural area in the Northwest Province of South Africa, experienced longer total delays than those seeking treatment at Selby and Chris Hani Baragwanath Hospitals in Johannesburg, a large metropolitan setting. Our fi ndings concur with those from Rwanda and Gambia showing that rural residence is predictive of prolonged total delay. 7, 22 It may be that Tshepong residents seek treatment in the informal health sector, have diffi culties accessing health care services or have low education levels. Although we did not analyse the cost of in-patient care, the cost of treatment for HIV-infected patients is high at Chris Hani Baragwanath Hospital. 21 About a quarter of the participants enrolled in this study reported currently consuming alcohol. Unlike other studies, which found that alcohol had no effect on delaying initiation of anti-tuberculosis treatment, 6, 23 we found that self-reported alcohol consumption is associated with overall patient and total delay.
Overall, we found that those living in less crowded households had lower odds of experiencing system and total delay. Crowding is associated with TB transmission. 24 It may be that living in a less crowded household leads to a lower index of suspicion by health care workers. Our fi ndings show that those who sought health care elsewhere before admission were likely to experience prolonged health care system delay and total delay in general. This concurs with fi ndings from Canada, 25 Ethiopia 26 and Tanzania. 27 Participants who visited other health practitioners and received treatment may have been confi dent that they would get better. While we note that health-seeking behaviour and health care services vary from country to country, most South African citizens seek treatment in the cheaper public sector. Unfortunately the fear of stigma overrides the benefi ts of treatment for both HIV and TB. 28, 29 In this study, patients on cotrimoxazole, prescribed to prevent opportunistic infections, were likely to experience patient, health care system and total delays; males were likely to experience system delay, while females experienced patient and total delay. The effect of broad-spectrum fl uoroquinolones, which have activity against TB, has previously been reported as a predictor of delays in TB diagnosis and treatment. 7, 23, 25, 30 Approximately 12% of the participants reported using cotrimoxazole. Although cotrimoxazole has some reported activity against TB in vitro, 31 there is no evidence that it slows the progression or delays the diagnosis of active TB.
In the overall analysis, we found that patients with WHO Stage 4 disease had higher odds of delays in TB diagnosis and treatment. This may be attributed to the acute opportunistic infections in severely immunesuppressed patients. It has previously been reported that patients with extra-pulmonary TB have significantly longer delays in TB diagnosis and treatment. 3 As our data were collected in a high TB and HIV incidence area, they may not be generalisable to other settings. Bias may have been introduced due to the use of differential diagnosis of TB as an inclusion criterion. Information on health-seeking behaviour was self-reported, and there is a possibility of recall bias. Immunological variables may not have been predictive of TB delay and treatment, probably because the majority of the patients had low CD4 counts and high HIV viral loads, thus limiting variability and lowering the predictive power of the logistic regression models.
CONCLUSION
More studies looking at cohorts of TB patients coinfected with HIV in high incidence areas are required to develop interventions that will alleviate the burden on the health care system. It is important to prevent and treat opportunistic infections early in TB-HIV co-infected patients. 3 . La mediana del retraso dependiente del paciente fue 28 días, del retraso dependiente del sistema de salud fue un día y del retraso total fue 28 días. Los factores pronósticos de un retraso total prolongado fueron el desempleo, el tratamiento en el hospital Tshepong, el consumo de alcohol, el índice de hacinamiento, la búsqueda previa de tratamiento, el tratamiento con la asociación trimetoprim y sulfametoxasol y el estadio clínico 4 de la enfermedad VIH según la escala de la Organización Mundial de la Salud. C O N C L U S I Ó N : El retraso de los pacientes para buscar atención por la TB en este medio con alta prevalencia de infección por el VIH es considerable. Se deben utilizar los factores que se detectaron como pronósticos de este retraso en la formulación de intervenciones que fomenten la búsqueda de atención y un diagnóstico más temprano de la enfermedad.
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